Dose-finding Study of GLPG0634 as add-on to Methotrexate in Active Rheumatoid Arthritis Participants (DARWIN1)
Clinical trial NCT01888874 · COMPLETED
Trial details
- NCT number
- NCT01888874
- Sponsor
- Lakefront Biotherapeutics NV
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-17
- Primary completion
- 2015-02-18
- Enrollment
- 599
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.